The HHV-6B U20 glycoprotein binds ULBP1, masking it from recognition by NKG2D and interfering with natural killer cell activation

Front Immunol. 2024 Jun 17:15:1363156. doi: 10.3389/fimmu.2024.1363156. eCollection 2024.

Abstract

Introduction: Human Herpesvirus 6B (HHV-6B) impedes host immune responses by downregulating class I MHC molecules (MHC-I), hindering antigen presentation to CD8+ T cells. Downregulation of MHC-I disengages inhibitory receptors on natural killer (NK) cells, resulting in activation and killing of the target cell if NK cell activating receptors such as NKG2D have engaged stress ligands upregulated on the target cells. Previous work has shown that HHV-6B downregulates three MHC-like stress ligands MICB, ULBP1, and ULBP3, which are recognized by NKG2D. The U20 glycoprotein of the related virus HHV-6A has been implicated in the downregulation of ULBP1, but the precise mechanism remains undetermined.

Methods: We set out to investigate the role of HHV-6B U20 in modulating NK cell activity. We used HHV-6B U20 expressed as a recombinant protein or transduced into target cells, as well as HHV-6B infection, to investigate binding interactions with NK cell ligands and receptors and to assess effects on NK cell activation. Small-angle X-ray scattering was used to align molecular models derived from machine-learning approaches.

Results: We demonstrate that U20 binds directly to ULBP1 with sub-micromolar affinity. Transduction of U20 decreases NKG2D binding to ULBP1 at the cell surface but does not decrease ULBP1 protein levels, either at the cell surface or in toto. HHV-6B infection and soluble U20 have the same effect. Transduction of U20 blocks NK cell activation in response to cell-surface ULBP1. Structural modeling of the U20 - ULBP1 complex indicates some similarities to the m152-RAE1γ complex.

Keywords: human herpesvirus; immune evasion; major histocompatibility complex; natural killer cell ligand; small-angle X-ray scattering; stress receptor; surface masking.

MeSH terms

  • GPI-Linked Proteins* / immunology
  • GPI-Linked Proteins* / metabolism
  • Glycoproteins / immunology
  • Glycoproteins / metabolism
  • Herpesvirus 6, Human* / immunology
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Killer Cells, Natural* / immunology
  • Killer Cells, Natural* / metabolism
  • Lymphocyte Activation* / immunology
  • NK Cell Lectin-Like Receptor Subfamily K* / immunology
  • NK Cell Lectin-Like Receptor Subfamily K* / metabolism
  • Protein Binding
  • Viral Proteins / immunology
  • Viral Proteins / metabolism

Substances

  • ULBP1 protein, human
  • GPI-Linked Proteins
  • NK Cell Lectin-Like Receptor Subfamily K
  • Viral Proteins
  • KLRK1 protein, human
  • Glycoproteins
  • Intracellular Signaling Peptides and Proteins

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by NIH grants U19-AI109858 (LS), R01-AI153828 (LS), R01-AI69099 (AH), T32-AI007349 (GW), and R01-AI137198 (LS).